Robert "Bob" Kessler is a co-founder PharmoRx Therapeutics. Together with David Bear, he patented the invention to develop novel uses of established dopamine-active agents in neuropsychiatry. Bob is a neuroradiologist with over 30 years of experience in both PET and MRI imaging, both at a clinical and research level. He holds patents both in development of dopamine D2 receptor ligands and in development of MRI pulse sequences.
This person is not in any offices